We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 76

News Bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 3 2014

The U.S. Food and Drug Administration (FDA) announces the availability of draft Guidance for Industry titled "Labeling for Human Prescription Drug

Court denies Myriad’s request to enjoin sale of rival BRCA1BRCA2 tests

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

A federal court in Utah has denied the request for a preliminary injunc- tion filed by Myriad Genetics against a rival company that offered tests

News Bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

The U.S. Food and Drug Administration requests comments on the estimated time burdens of a proposed study that "will investigate the impact of

News Bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 13 2014

The U.S. Patent and Trademark Office requests comments by March 3, 2014, on the revision of a previously approved information collec- tion concerning

Myriad Genetics, gene by gene settle BRCA infringement dispute

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 13 2014

According to a joint news release, Myriad Genetics, Inc. and other owners of the BRCA1 and BRCA2 gene patents have settled patent infringe- ment

Biosimilar development costs may affect savings potential

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 30 2014

According to Pharm Exec Senior Editor Ben Comer, the biosimilars that were supposed to save consumers and taxpayers money as "the first wave of

Myriad Genetics brings new BRCA1BRCA2 infringement suits

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 12 2013

Myriad Genetics now reportedly has six pending infringement lawsuits involving its BRCA1 and BRCA2 patents, with Invitae Corp. and Laboratory Corp

Exhaustion doctrine applied to method patent

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 21 2013

A divided Federal Circuit Court of Appeals panel has determined that a method patent holder that gave away 60 percent of the blood-glucose testing

CRS issues overview of IP issues for gene-related discoveries

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 29 2013

The Congressional Research Service (CRS) recently released a report titled "Gene Patents: A Brief Overview of Intellectual Property Issues." The

Indian pharma interests challenge U.S. allegations of discriminatory treatment

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • August 29 2013

According to a news source, the Indian Pharmaceutical Alliance (IPA) has challenged U.S. allegations that India's Patent Act discriminates against